Age-related macular degeneration is a leading cause of visual impairment and severe vision
loss. Clinically, it is classified as early-stage (medium-sized drusen and retinal pigmentary …

Intravitreal anti-vascular endothelial growth factor (VEGF) drugs have revolutionized the
treatment of neovascular age-related macular degeneration (NVAMD). However, many …

Central serous chorioretinopathy (CSC) is a common cause of central vision loss, primarily
affecting men 20–60 years of age. To date, no consensus has been reached regarding the …

Pachychoroid is a relatively novel concept describing a phenotype characterized by
attenuation of the choriocapillaris overlying dilated choroidal veins, and associated with …

Polypoidal choroidal vasculopathy (PCV) is an age-related macular degeneration (AMD)
subtype and is seen particularly in Asians. Previous studies have suggested disparity in …

Purpose To develop consensus terminology in the setting of polypoidal choroidal
vasculopathy (PCV) and to develop and validate a set of diagnostic criteria not requiring …

Importance Polypoidal choroidal vasculopathy (PCV) is common in Asian populations, but
an optimal treatment approach remains to be confirmed. Objective To evaluate intravitreal …

Importance The 2-year efficacy and safety of combination therapy of ranibizumab
administered together with verteporfin photodynamic therapy (vPDT) compared with …

We evaluated the efficacy and safety of loading phase treatment with intravitreal
brolucizumab for neovascular age-related macular degeneration (nAMD) with type 1 …

Purpose To evaluate the vascular changes in vortex veins at the posterior pole in
pachychoroid spectrum diseases, including central serous chorioretinopathy (CSC) …